Clinical Trial Update: A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study of JNJ-39758979 in adult Japanese patients with moderate atopic dermatitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• JNJ-39758979

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Dermatitis, Atopic | Phase 2 | Status: TERMINATED